The PEERLESS II Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1200 participants.

Also called NCT06055920

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,200 participants (enrolled count) (from the registry)
Sponsor
  • Inari Medical Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06055920
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Belgium, Canada, Denmark, France, Germany, Spain, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06055920. Randomized; no masking; primary purpose treatment. Start 2023-11-17 (actual); primary completion 2026-07-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The PEERLESS II Study
Intervention (Device)
FlowTriever System
Intervention (Drug)
Anticoagulation Agents
Lead sponsor
Inari Medical (class: industry)

Record details

Record id
cardio:ct-nct06055920
Content hash
1a2987056d7abb22af3d1585986157c4e3f8bc856f48881ea38644397cc8f144